Synthesis and biological evaluation of decavanadate Na4Co(H2O)6V10O28·18H2O - 05/01/09
pages | 5 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Abstract |
We have reported the synthesis and biological evaluation of a decavanadate Na4Co(H2O)6V10O28·18H2O (CoV10) designed as a potential antitumoral agent. The human cancer cell lines SMMC-7721 (liver cancer) and SK-OV-3 (ovary cancer) were tested for their viability by the MTT method in vitro, which showed that the compound exhibited a remarkable activity against two cell lines with IC50 values smaller than 0.24μg/mL, 0.32μg/mL, respectively. CoV10 showed the tumor growth suppression for Hep-A-22 (mice liver cancer) in tumor bearing mice in vivo. In addition, using flow cytometry analysis, the ratio of apoptotic cells was up to 8.33% with treatment of CoV10 at 1.56μg/mL after 30min, suggesting that the antitumoral activity of CoV10 comes from the activation of the apoptotic pathway.
Le texte complet de cet article est disponible en PDF.Keywords : Decavanadate, Antitumoral activity, Apoptosis
Plan
Vol 63 - N° 1
P. 51-55 - janvier 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?